Pivotal Phase 2b clinical trial (ELPIS II) evaluating Lomecel-Bâ„¢ (laromestrocel) in Hypoplastic Left Heart Syndrome (HLHS), a rare pediatric ...
We remain committed to bringing an ophthalmic bevacizumab to market in the United States and providing retina patients suffering from wet AMD with a much needed treatment option that has the potential ...
Fapon Biopharma, a biotech innovator in developing therapeutic antibodies and fusion proteins, is pleased to announce that the U.S. Food and Drug ...